Media Mention

Bert Rein Comments on High-Profile First Amendment Supreme Court Case

The Wall Street Journal
April 26, 2011

Wiley Rein senior partner Bert W. Rein was referenced in the Wall Street Journal's Health Blog in an article on Sorrell v. IMS Health Inc., a First Amendment case heard by the U.S. Supreme Court on Tuesday, April 26. Sorrell challenges a Vermont law prohibiting the sale of prescription data to market drugs, unless prescribing doctors first consent. Mr. Rein told the paper that if pharmaceutical companies could no longer use prescribing information, there would be no one to subsidize its other non-commercial uses, including drug recalls.

Mr. Rein filed an amicus brief in the case on behalf of the patient advocacy groups Genetic Alliance and the National Organization for Rare Disorders. Last week, The National Law Journal's Supreme Court Insider recognized the filing as its "Brief of the Week."

Read Time: 1 min

Related Professionals

Contact

Maria Woehr Aronson
Director of Communications
202.719.3132
maronson@wiley.law 

Molly Peterson
Senior Communications Manager
202.719.3109
mmpeterson@wiley.law

Jump to top of page

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytical Cookies

Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.